Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 357.6 INR -1.25% Market Closed
Market Cap: 243.2B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Natco Pharma Ltd

Current Assets 40.2B
Cash & Short-Term Investments 18.5B
Receivables 12B
Other Current Assets 9.8B
Non-Current Assets 28.8B
Long-Term Investments 1.4B
PP&E 24.4B
Intangibles 1.9B
Other Non-Current Assets 1.1B
Current Liabilities 9.7B
Accounts Payable 2.4B
Short-Term Debt 3.6B
Other Current Liabilities 3.7B
Non-Current Liabilities 804m
Long-Term Debt 53m
Other Non-Current Liabilities 751m

Balance Sheet
Natco Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
133
452
358
217
283
198
258
1 111
1 319
9 529
Cash
133
452
358
217
283
198
258
1 111
1 319
704
Cash Equivalents
0
0
0
0
0
0
0
0
0
8 825
Short-Term Investments
7
221
321
2 284
3 977
715
3 983
2 950
6 612
8 963
Total Receivables
2 012
2 867
4 971
6 848
6 077
7 029
5 903
8 379
10 336
11 979
Accounts Receivables
1 924
2 616
4 752
6 375
5 062
5 513
4 129
6 206
10 168
11 889
Other Receivables
88
251
219
473
1 015
1 516
1 774
2 173
168
90
Inventory
2 200
3 573
3 489
4 384
5 908
6 987
9 104
8 620
8 089
7 005
Other Current Assets
526
1 257
1 734
7 574
7 227
8 327
4 125
3 912
3 647
2 759
Total Current Assets
4 878
8 370
10 873
21 307
23 472
23 256
23 373
24 972
30 003
40 235
PP&E Net
7 930
9 164
11 635
14 927
18 561
20 936
22 372
23 084
23 034
24 350
PP&E Gross
0
9 164
11 635
14 927
18 561
20 936
22 372
23 084
23 034
0
Accumulated Depreciation
0
2 679
3 184
3 800
4 576
5 485
6 627
7 940
9 123
0
Intangible Assets
50
55
58
59
87
88
94
822
1 326
1 371
Goodwill
374
0
0
0
0
0
0
507
552
560
Note Receivable
536
591
554
701
633
726
451
625
616
261
Long-Term Investments
27
1
1
81
199
836
1 594
1 044
873
1 398
Other Long-Term Assets
27
36
55
76
79
36
35
37
170
888
Other Assets
374
0
0
0
0
0
0
507
552
560
Total Assets
13 822
N/A
18 217
+32%
23 176
+27%
37 151
+60%
43 031
+16%
45 878
+7%
47 919
+4%
51 091
+7%
56 574
+11%
69 063
+22%
Liabilities
Accounts Payable
1 253
2 756
2 627
2 691
2 170
2 554
1 462
1 618
2 638
2 355
Accrued Liabilities
121
155
306
332
314
300
321
370
446
0
Short-Term Debt
1 765
984
2 216
1 732
3 863
3 277
163
165
1 650
3 632
Current Portion of Long-Term Debt
463
142
0
0
0
8
2 667
4 075
6
27
Other Current Liabilities
538
894
1 116
1 165
940
714
643
876
2 091
3 714
Total Current Liabilities
4 140
4 931
6 265
5 920
7 287
6 853
5 256
7 104
6 831
9 728
Long-Term Debt
970
0
0
0
0
9
9
80
11
53
Deferred Income Tax
116
147
150
139
116
259
413
301
124
2
Minority Interest
50
49
41
38
20
112
18
0
0
0
Other Liabilities
100
133
227
332
718
910
1 007
970
870
749
Total Liabilities
5 376
N/A
5 260
-2%
6 683
+27%
6 429
-4%
8 141
+27%
8 143
+0%
6 703
-18%
8 455
+26%
7 836
-7%
10 532
+34%
Equity
Common Stock
332
348
349
369
365
364
365
365
365
358
Retained Earnings
5 338
6 554
10 055
15 288
20 601
23 748
26 979
27 822
34 045
58 173
Additional Paid In Capital
2 783
6 112
6 178
15 206
14 048
13 729
13 915
14 078
14 065
0
Other Equity
7
57
89
141
124
106
43
371
263
0
Total Equity
8 446
N/A
12 957
+53%
16 493
+27%
30 722
+86%
34 890
+14%
37 735
+8%
41 216
+9%
42 636
+3%
48 738
+14%
58 531
+20%
Total Liabilities & Equity
13 822
N/A
18 217
+32%
23 176
+27%
37 151
+60%
43 031
+16%
45 878
+7%
47 919
+4%
51 091
+7%
56 574
+11%
69 063
+22%
Shares Outstanding
Common Shares Outstanding
166
174
174
184
183
182
182
183
182
179

See Also

Discover More